Trial intelligence / Profile preview

PERIVERSION-2: Amiodarone Regimens After Electrical Cardioversion in Persistent AF

NCT07273994Phase 4Recruiting

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Nov 2025
Primary completion
Dec 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Nov 2025; status: recruiting.

02

Drugs

amiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT07273994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07273994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call